Sarepta Therapeutics Inc (SRPT)

01:03 AM

Baird Maintains Neutral Rating, Lowers Price Target on SRPT | SRPT Stock News - GuruFocus

01:03 AM

12:55 PM

SRPT Q3 Earnings Miss Estimates, Stock Dips on DMD Study Failure - Zacks Investment Research

12:55 PM

12:41 PM

Scandal and controversy take toll on FDA credibility - statnews.com

12:41 PM

12:37 PM

Sarepta (SRPT) Shares Plummet Over 33% - GuruFocus

12:37 PM

12:33 PM

Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance - inkl

12:33 PM

12:19 PM

Sarepta (SRPT) Faces Stock Plunge Amid Clinical Trial Setbacks - GuruFocus

12:19 PM

12:18 PM

Sarepta stock plummets as confirmatory Duchenne trial fails - The Business Journals

12:18 PM

12:11 PM

Top Stock Movers Now: Palantir, Sarepta Therapeutics, Denny's, and More - MSN

12:11 PM

12:11 PM

Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It - Benzinga

12:11 PM

11:11 AM

Sarepta Therapeutics Stock Tumbles After Trial Data - Schaeffer's Investment Research

11:11 AM

11:09 AM

Palantir, Uber, Sarepta, Tesla, Norwegian Cruise Line, Hertz, AMD, and More Movers - Barron's

11:09 AM

10:36 AM

Sarepta (SRPT) Stock Plummets Over 30% - GuruFocus

10:36 AM

10:19 AM

Sarepta shares tumble on trial failure, weak Elevidys outlook - Reuters

10:19 AM

10:14 AM

Sarepta Plunges On Study Failures, Gene Therapy Outlook - Investor's Business Daily

10:14 AM

10:00 AM

Stocks to Watch Tuesday: Palantir, Sarepta, Tesla -- WSJ - 富途牛牛

10:00 AM

09:58 AM

Sarepta Stock Dives 35% After Earnings Report. Why Shares Are Crashing. - Barron's

09:58 AM

09:48 AM

Sarepta Therapeutics (SRPT) Stock: Clinical Failure Triggers Massive Selloff - parameter.io

09:48 AM

09:30 AM

Sarepta Therapeutics (SRPT) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo! Finance UK

09:30 AM

09:09 AM

Sarepta Duchenne drugs come up short in confirmatory test - BioPharma Dive

09:09 AM

09:00 AM

Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

09:00 AM

08:48 AM

FDA Duchenne Failure Hits Sarepta Amid 3Q25 Earnings Beat (NASDAQ:SRPT) - Seeking Alpha

08:48 AM

08:40 AM

Sarepta’s DMD Exon-Skippers Fail Confirmatory Study, Stock Craters - BioSpace

08:40 AM

08:30 AM

Stocks making the biggest moves premarket: Uber, Sarepta, Palantir, Norwegian Cruise and more - CNBC

08:30 AM

08:13 AM

Sarepta shares slide as DMD treatment woes pile up - pharmaphorum

08:13 AM

08:13 AM

Needham Maintains Sarepta Therapeutics(SRPT.US) With Sell Rating - 富途牛牛

08:13 AM

08:08 AM

Sarepta Says Older Muscle Disease Drugs Failed Confirmatory Trial - Bloomberg

08:08 AM

08:05 AM

Sarepta Earnings Beat Expectations. Why the Stock Is Down 40%. - Barron's

08:05 AM

07:47 AM

Sarepta slumps after approved muscle disorder drugs fail confirmatory trial - TradingView

07:47 AM

07:45 AM

Palantir, Sarepta, Tesla, Uber, Pfizer, Norwegian Cruise Line, Amazon, AMD, and More Movers - Barron's

07:45 AM

07:42 AM

Morning Market Movers: DENN, SRPT, JELD, ICHR See Big Swings - RTTNews

07:42 AM

07:41 AM

Sell Rating for Sarepta Therapeutics Amid ESSENCE Study Disappointment and Reimbursement Concerns - TipRanks

07:41 AM

07:22 AM

Sarepta slumps as trial failure deepens woes for drugmaker - Yahoo! Finance Canada

07:22 AM

07:13 AM

Two of Sarepta’s DMD drugs fail to meet primary endpoint in confirmatory trial - Yahoo Finance

07:13 AM

06:59 AM

Multi asset correlation models including Sarepta Therapeutics Inc.Weekly Stock Analysis & Community Consensus Picks - newser.com

06:59 AM

06:52 AM

Relative strength of Sarepta Therapeutics Inc. in sector analysisPortfolio Return Report & Long-Term Growth Plans - newser.com

06:52 AM

06:44 AM

Sarepta Stock Tumbles 40%. Why the Biotech’s Shares Are Sinking. - MSN

06:44 AM

06:36 AM

Dow Futures Edge Lower On Pullback Fears: PLTR, SRPT, TSLA, AMD Among Stocks To Watch - Stocktwits

06:36 AM

06:35 AM

Baird lowers Sarepta Therapeutics stock price target to $15 on ESSENCE trial failure - Investing.com Nigeria

06:35 AM

06:33 AM

Analyzing drawdowns of Sarepta Therapeutics Inc. with statistical toolsTrade Analysis Report & Risk Controlled Daily Trade Plans - newser.com

06:33 AM

06:27 AM

Palantir, Sarepta, Tesla, Amazon, AMD, Pfizer, and More Stock Market Movers - Barron's

06:27 AM

05:31 AM

Palantir, Sarepta, Amazon, AMD, Pfizer, and More Stock Market Movers - Barron's

05:31 AM

04:42 AM

Sarepta Therapeutics (SRPT) Stock Crashes as Nine-Year Trial Ends in Disappointment - CoinCentral

04:42 AM

04:29 AM

Biggest stock movers Tuesday: PLTR, SRPT, and more (NASDAQ:PLTR) - Seeking Alpha

04:29 AM

04:29 AM

Sarepta slumps as gene therapy setback adds to drug pipeline woes - Yahoo Finance

04:29 AM

04:16 AM

Pinnacle Associates Ltd. Has $997,000 Holdings in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

04:16 AM

04:13 AM

Stocks to Watch Tuesday: Palantir, Sarepta, Tesla - The Wall Street Journal

04:13 AM

03:59 AM

Is Sarepta Therapeutics Inc. stock supported by strong cash flowsJuly 2025 Levels & Risk Managed Investment Signals - newser.com

03:59 AM

03:35 AM

Will Sarepta Therapeutics Inc. (AB3A) stock test record highs in 2025July 2025 Gainers & Consistent Income Trade Ideas - newser.com

03:35 AM

03:35 AM

Will Sarepta Therapeutics Inc. stock benefit from sector rotationQuarterly Market Review & Technical Confirmation Alerts - newser.com

03:35 AM

03:28 AM

Sarepta Therapeutics Swings to Q3 Adjusted Loss, Revenue Falls; Shares Down Pre-Bell - MarketScreener

03:28 AM

03:18 AM

What technical charts say about Sarepta Therapeutics Inc. stockJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com

03:18 AM

03:00 AM

What technical models suggest about Sarepta Therapeutics Inc.’s comeback - newser.com

03:00 AM

02:55 AM

Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback - Stocktwits

02:55 AM

02:05 AM

Sarepta Therapeutics (SRPT) to Join S&P SmallCap 600 - GuruFocus

02:05 AM

02:02 AM

Why Sarepta Therapeutics Shares Tumbled Today - TipRanks

02:02 AM

01:48 AM

Sarepta Stock’s (SRPT) Painful Plunge! Is There Any Hope Left for Investors after DMD Trial Miss? - TipRanks

01:48 AM

01:13 AM

Earnings Snapshot: Sarepta Q3 beat; ESSENCE study did not meet statistical significance on primary endpoint - MSN

01:13 AM

12:00 PM

Sarepta Therapeutics Inc (SRPT) Q3 2025 Earnings Call Highlights: Resilient Revenue Amidst ... - Yahoo Finance

12:00 PM

Nov 03, 2025

Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback - Stocktwits

Nov 03, 2025

Nov 03, 2025

Sarepta Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 03, 2025

Nov 03, 2025

Transcript : Sarepta Therapeutics, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025

Nov 03, 2025

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - BioSpace

Nov 03, 2025

Nov 03, 2025

Sarepta Therapeutics (SRPT): Assessing Valuation After Q3 Earnings Reveal Swing to Net Loss - simplywall.st

Nov 03, 2025

Nov 03, 2025

Sarepta's shares sink after antisense DMD therapies fail confirmatory trial - FirstWord Pharma

Nov 03, 2025

Nov 03, 2025

Sarepta Therapeutics: Q3 Earnings Snapshot - CTPost

Nov 03, 2025

Nov 03, 2025

Sarepta Therapeutics Outpaces Forecasts On Gene Therapy Strength - Finimize

Nov 03, 2025

Nov 03, 2025

Earnings call transcript: Sarepta Therapeutics beats Q3 2025 EPS forecast - Investing.com

Nov 03, 2025